Evaluate the Effect of Bone Marrow Derived Cd133+ Cells in Patient With Osteonecrosis of Femoral Head

计划入组 10 人 · 首次发布于 2010 年 9 月 9 日

Autologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis Pigmentosa

计划入组 50 人 · 首次发布于 2016 年 3 月 16 日

Multiple Transplantation of Bone Marrow Derived CD133 Cell in Cerebral Palsy

计划入组 8 人 · 首次发布于 2013 年 1 月 8 日

Allogenic bone marrow-derived mesenchymal stem cells

CS-10BR05

KI-MSC-PL-205

STEM CELLS ARABIA

Jordan

Personalized Stem Cells, Inc.

United States

KLSMC Stem Cells, Inc.

Phase 1/2 Trial Demonstrates Safety and Efficacy of Autologous CD133+ Stem Cell Therapy for Asherman Syndrome

Mesenchymal Stem Cell Therapy Shows Promise for Lumbar Facet Joint Arthropathy

Yeast Beta-Glucan Supplement Reprograms Bone Marrow Stem Cells to Restore Anti-Tumor Immunity in Obesity